Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

FWBI First Wave BioPharma

1.840
+0.190+11.52%
Close 10/05 16:00 ET
1.970
+0.130+7.07%
Post Mkt Price 10/05 19:55 ET
High
2.340
Open
1.680
Turnover
2.91M
Low
1.680
Pre Close
1.650
Volume
1.43M
Market Cap
2.55M
P/E(TTM)
Loss
52wk High
106.500
Shares
1.39M
P/E(Static)
Loss
52wk Low
1.190
Float Cap
2.54M
Bid/Ask %
42.86%
Historical High
1680.000
Shs Float
1.38M
Volume Ratio
3.09
Historical Low
1.190
Dividend TTM
--
Div Yield TTM
--
P/B
-0.18
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
103.94%
Amplitude
40.00%
Avg Price
2.035
Lot Size
1
Float Cap
2.54M
Bid/Ask %
42.86%
Historical High
1680.000
Shs Float
1.38M
Volume Ratio
3.09
Historical Low
1.190
Dividend TTM
--
P/B
-0.18
Dividend LFY
--
Turnover Ratio
103.94%
Amplitude
40.00%
Avg Price
2.035
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm involves in therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD,FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
CEO: Mr. James Sapirstein
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...